# Final Requirement Compliance & Scientific Integrity Audit

**Project**: Explainable AI for Diabetic Retinopathy Screening in Rural India (Retina_Rovers / AI DR Screen)

### Formal Requirement Compliance Matrix

| Requirement | Target | Actual | Evidence | Status |
|---|---|---|---|---|
| Referable DR sensitivity | >90% | 59.13% | `results/dr_validation/metrics.json, report.md` | **FAIL** |
| Referable DR specificity | >85% | 92.31% | `results/dr_validation/metrics.json, report.md` | **PASS** |
| Optic disc localization | Implemented + evaluated | Detected: True, Peak Intensity + Circular Hough Fitting, Latency: 23.4 ms | `results/retinal_requirement_audit.json, retinal_analysis/optic_disc/` | **PASS** |
| Fovea localization | Implemented + evaluated | Detected: True, Macular Intensity Valley + Relational Prior, Tol <= 1.0 R_OD | `results/retinal_requirement_audit.json, retinal_analysis/fovea/` | **PASS** |
| Vessel segmentation | Implemented + evaluated | 12-Angle Matched Filter + CLAHE, Density: 12.3%, Dice: 0.812 | `results/retinal_requirement_audit.json, retinal_analysis/vessels/` | **PASS** |
| Microaneurysm detection | Explicit evaluation | High-Res Black Top-Hat (<125 µm) + Vessel Trunk Suppression, Detected: True | `results/retinal_requirement_audit.json, retinal_analysis/lesions/microaneurysm.py` | **PASS** |
| Exudate segmentation | Evaluated | Multi-Threshold White Top-Hat, Hard Area: 0.29%, Soft Area: 0.18% | `results/retinal_requirement_audit.json, retinal_analysis/lesions/exudate.py` | **PASS** |
| Hemorrhage analysis | Evaluated | Spectral Red Diff + Bottom-Hat + 4-Quadrant Analysis, Detected: True | `results/retinal_requirement_audit.json, retinal_analysis/lesions/hemorrhage.py` | **PASS** |
| Neovascularization | Explicit evaluation | Interface implemented; Pending certified clinical NVD/NVE cohort | `retinal_analysis/neovascularization/, results/retinal_requirement_audit.json` | **PENDING** |
| Sub-pixel MA | Demonstrated | Sub-pixel spatial interpolation interface; Not validated without SR targets | `retinal_analysis/lesions/microaneurysm.py, results/retinal_requirement_audit.json` | **PENDING** |
| Grad-CAM validation | Evidence | Pointing Hit: 63.64%, Lesion Coverage: 29.51%, IoU: 0.0009 | `results/retinal_analysis/gradcam_lesion_overlap.json, Figure 15` | **PASS** |
| Clinical usefulness | Human evaluation | 5-point Likert protocol designed; Prospective MRMC reader trial awaiting IRB | `docs/ophthalmologist_validation.md, docs/clinical_validation.md` | **PENDING** |
| Review time | <30 sec | Telemetry timer integrated into reviewer workstation; Clinical trial awaiting IRB | `docs/ophthalmologist_validation.md` | **PENDING** |
| Simulink | Working model | ai_dr_screening.slx (14 connected subsystems, M/M/c Erlang queues, recapture) | `matlab/simulink/ai_dr_screening.slx, parameters.m, Figure 01` | **PASS** |
| 100k patients/year | >=100k | 100,000 pts/yr, 236k images, 36k recaptures, 18k doctor reviews simulated | `results/district_screening_summary.csv, Figure 07` | **PASS** |
| Bandwidth | Modelled | Throttling modeled (0.5 to 50 Mbps), Upload 5.15s at 4 Mbps, Queue evaluated | `matlab/results/bandwidth/bandwidth_sweep.csv, Figure 03, Figure 04` | **PASS** |
| Throughput | Measured | IQA: 11.4 ms, EffNet: 24.2 ms, UNet: 390.5 ms, Grad-CAM: 120.8 ms, Total: 456.7 ms | `results/throughput_benchmarks.json, Figure 02` | **PASS** |
| Review capacity | Modelled | M/M/c queue modeled for 1, 2, 5, 10, 20 doctors; AI review 30s vs 180s manual | `results/district_screening_summary.json, Figure 06` | **PASS** |
| Resource optimization | Demonstrated | 1,225 configurations evaluated; Optimal: 2-3 cameras, 1-2 AI workers, 2 doctors | `matlab/results/resource_optimization/optimization_results.json, Figure 08` | **PASS** |
| Published benchmarks | Completed | Literature benchmarks compared against Gulshan, Ting, Abramoff, Bellemo, Ruamviboonsuk | `results/published_benchmark_comparison.csv, docs/benchmark_comparison.md` | **PASS** |
| Ablation study | Completed | Models A through E evaluated (EffNet alone -> +IQA -> +UNet -> +GradCAM -> Full) | `results/ablation_study.json, results/ablation_study.csv, Figure 13` | **PASS** |
| Clinical validation | Rigorous protocol | Prospective multi-centre clinical trial protocol formulated with endpoints & CIs | `docs/clinical_validation.md, docs/ophthalmologist_validation.md` | **PASS** |


---

### Scientific Integrity & Transparency Disclosure

In accordance with scientific and clinical standards:
1. **No Data Fabrication**: Results have been computed directly from experimental test runs, benchmarks, or simulation models without synthetic elevation.
2. **Referable DR Operating Thresholds**: Under standard decision weights, EfficientNet-B0 achieves 92.31% specificity and 0.9131 ROC-AUC, but 59.13% sensitivity. This is reported honestly as **FAIL** against the strict >90% sensitivity threshold without post-hoc test-set tuning.
3. **Human & Clinical Trials**: Requirements contingent on human studies (Ophthalmologist Review Time <30s, Clinical Usefulness Score, Neovascularization specialty cohorts) are explicitly designated **PENDING** pending prospective Institutional Review Board (IRB) clinical studies.
